Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Bigger, More Expensive Healthcare Practices Not Necessarily Better

Ronnie Cohen  |  May 15, 2017

(Reuters Health)—You might not get what you pay for when it comes to healthcare, a new study hints.

A report in Health Affairs on May 2 found little association between how much physician practices charged and patients’ perceptions of their quality of care.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We’re asking consumers to make a lot of decisions about healthcare purchasing without a lot of information. Price is not really a definitive signal of quality,” says lead author Eric T. Roberts, a health-services researcher at Harvard Medical School in Boston.

“Practices with higher prices perform no better in terms of patients’ ratings of their care,” he says in a phone interview.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Working with nationwide databases, Roberts and his team looked at the fees practices had negotiated with commercial insurance companies. On average, high-price practices charged $84.45 for an office visit—36% more than the charge at the average low-price practice, the study found.

Roberts and colleagues then looked at survey data and insurance claim information from more than 31,000 patients at those same practices who were insured through Medicare, the federal insurance policy for the elderly and disabled.

The researchers studied these patients because, under Medicare, the government sets non-negotiable fees. Medicare patients would have been unaware of the price differential and therefore would have been free from any influence of knowing the cost, making it easier for researchers to tell whether practices that negotiated above-average prices with commercial insurers for their non-Medicare patients delivered better care in general.

Medicare patients in high-price practices did report better coordination and management of their care, were more likely to see doctors within 15 minutes of scheduled appointments and were slightly more likely to receive flu and pneumonia vaccines. Otherwise, however, based on their survey responses, they didn’t feel they received more valuable care than patients in lower-price practices in the same geographic areas.

Researchers found no significant differences in overall ratings of care or doctors, timely access to care and interactions with primary physicians. Higher prices failed to lead to fewer hospitalizations, and patients in high-price practices were no more likely to get mammograms or other preventive or acute care.

The study debunks the myth that more expensive healthcare is superior healthcare, says Martin Gaynor, an economics and health policy professor at the Heinz College at Carnegie Mellon University in Pittsburgh.

“Don’t just assume that because this practice is more expensive, the care is going to be better,” Gaynor, who was not involved with the study, says in a phone interview. “There’s no consistent finding across the board that quality is better for patients who go to more expensive practices.”

Page: 1 2 | Single Page
Share: 

Filed under:Practice Support Tagged with:alternative therapiescostsHealth carepatient care

Related Articles

    Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment

    June 14, 2017

    While members of Congress debate healthcare legislation, rheumatologists say many of their patients struggle to afford everything from generic drugs to insurance copayments for physical therapy. “It’s a mess. The cost of prescriptions and the rationale for those rising costs in the U.S. right now—it’s just a mess,” says James R. O’Dell, MD, Stokes-Shackleford Professor of…

    The Birth and Growth of Biotechnology, and the Impact of Biologic Drugs on Rheumatology

    June 15, 2017

    Here’s a trivia question: Where were the big ideas for the field of biotechnology first discussed? Answer: At a since-demolished delicatessen in Waikiki Beach, Hawaii. Go figure. The year was 1972, and Stanley Cohen, MD, professor of medicine at Stanford University in Palo Alto, Calif., and Herbert Boyer, PhD, a former professor and biochemist at the…

    Major Drugmakers Push Back in U.S. Price Debate

    January 15, 2016

    SAN FRANCISCO (Reuters)—With a backlash brewing over the price of medicines in the U.S., drugmakers are pushing back with a new message: Most people don’t pay retail. Top executives from Eli Lilly and Co, Merck & Co and Biogen Inc. said in interviews with Reuters this week that the media focus on retail, or “list…

    U.S. Supreme Court Upholds Obamacare Insurance Subsidies

    June 25, 2015

    WASHINGTON (Reuters)—The U.S. Supreme Court preserved President Barack Obama’s signature healthcare law on Thursday, upholding crucial tax subsidies while turning aside a conservative legal challenge that could have doomed the law. “After more than 50 votes in Congress to repeal or weaken this law, after a presidential election based in part on preserving or repealing…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences